National Aeronautics and Space Administration May 18, 2011 – Federal Register Recent Federal Regulation Documents

This notice is issued in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant a partially exclusive license in the United States to practice the inventions described and claimed in USPN 6,133,036, Preservation of Liquid Biological Samples, NASA Case No. MSC- 22616-2, and USPN 6,716,392, Preservation of Liquid Biological Samples, NASA Case No. MSC-22616-3 to ApoCell, Inc., having its principal place of business in Houston, Texas. The patent rights in these inventions have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective partially exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.